QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Sometimes team building means working on your backhand
🎾Last week, we traded data models for tennis rackets and hit the courts with professional coaches for a fun afternoon of tennis.
Team Quantify includes both seasoned players and enthusiastic beginners, but the real goal was time together outside our usual element.
Unlock Global Insights with Nordic RWE
October is a busy month for Quantify Research!
We’re heading across Europe and the US to share how Nordic real-world evidence (RWE) drives global impact for Market Access, HEOR, and beyond.
Nordic data is globally recognized as a gold standard, thanks to:
✅ 27M+ population coverage across Sweden, Denmark, Norway & Finland
✅ Rich, linked datasets spanning hospitals, pharmacies, cancer registries & more
✅ Exceptional support for rare disease research
✅ Robust HEOR insights connecting outcomes […]
🧠Quantifying burden across borders: Japanese Encephalitis in APAC
At today’s ISPOR Real-World Evidence Summit 2025 , Puneet Kaushik presented new insights into the economic burden of Japanese Encephalitis(JE) across Asia-Pacific.
🔍 Despite vaccines and treatments, JE continues to strain health systems through:
• High inpatient and ICU demands
• Significant productivity losses—up to 860 workdays per case
• Wide cost variability: from $106 to $1,644 per case across countries
This systematic review drew from real-world data in China, Bangladesh, Indonesia, the Philippines and […]
Off to Tokyo: Real-world evidence through an APAC lens
Quantify’s Puneet Kaushik is heading to the ISPOR Real-World Evidence Summit 2025 in Tokyo.
He’ll be presenting new findings on:
🧠 RWD317: The Burden of Japanese Encephalitis in Asia-Pacific
📅 𝘗𝘰𝘴𝘵𝘦𝘳 𝘚𝘦𝘴𝘴𝘪𝘰𝘯 2
📍 𝘗𝘰𝘴𝘵𝘦𝘳 𝘉𝘰𝘢𝘳𝘥 4018
🕒 𝘛𝘶𝘦𝘴𝘥𝘢𝘺, 30 𝘚𝘦𝘱𝘵𝘦𝘮𝘣𝘦𝘳, 13:00–14:00 (𝘋𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯 𝘱𝘦𝘳𝘪𝘰𝘥)
If you’re attending, don’t miss the chance to connect with Puneet. He’s keen to exchange thoughts on:
• Evidence Review & Synthesis 🔍
• Medical Writing & Editorial Services ✍
• Real-World Evidence Applications […]